Introduction
Cherubism is a rare genetic bone dysplasia characterized by symmetrical jawbone lesions causing severe facial and dental deformity and associated with mutations of the SH3-domain binding protein 2 (SH3BP2) gene. The most frequent SH3BP2 mutations affect exon 9, leading to the substitution of amino acids Arg415, Pro418, or Gly420 within an RSPPDG motif of the protein 3BP2 (1-3). 3BP2 is a cytoplasmic adapter involved in leukocyte activation (4) (5) (6) (7) , osteoclast differentiation, and bone remodeling (8, 9) . 3BP2 signals downstream of diverse leukocyte membrane receptors through interactions with SRC and SYK kinases, PLCγ, and VAV GEF (2, 3) .
Determinant insights into the mechanism underlying cherubism came from the analysis of the Sh3bp2 P416R genetic mouse model of cherubism (10) . Whereas heterozygous cherubic mice showed no significant phenotype, homozygous cherubic animals developed systemic inflammation and severe osteopenia (10, 11) . This phenotype has been linked to exacerbated activities of intracellular signaling components resulting from the accumulation of proteasomeresistant mutant 3BP2 proteins in mouse osteoclasts (12) .
However, several aspects of cherubism are still unclear, including the craniofacial manifestation, the variable penetrance, and its mode of transmission. Whereas the disease is dominantly transmitted in humans, it is recessively transmitted in cherubic mouse models housed under germ-free conditions. Together, these aspects suggest that additional genetic or environmental factor or factors may influence the onset of the disease. Microbial infections of the oral cavity dramatically affect local inflammation and subsequent bone-destructive diseases, such as periodontitis (13) . We thus hypothesized that pathogenic microbial challenge may contribute to the development of the cherubism phenotype by exacerbating inflammatory responses of host macrophages. Here, we demonstrate that 3BP2 deficiency in the mouse alters macrophage responses to microbial stimuli. Conversely, we show that TLR stimulation and one Sh3bp2 cherubic allele have a dramatic cooperative effect on macrophage activation and inflammatory responses. Our study in mice suggests that microbial infection participates in the development of cherubism in humans, thereby opening new therapeutic avenues.
Results and Discussion
In mice, homozygosity for a cherubism mutation in Sh3bp2 caused an autoinflammatory syndrome initiated by macrophages producing high levels of TNF-α (10). Because macrophages are important components of the innate immune system involved in pathogen recognition (14) , we hypothesized that infection may contribute to the onset of the disease in humans. To test this hypothesis, we first determined the dependence of TLR stimulation by pathogen-associated molecular patterns (PAMPs) on 3BP2 expression Cherubism is a rare autoinflammatory bone disorder that is associated with point mutations in the SH3-domain binding protein 2 (SH3BP2) gene, which encodes the adapter protein 3BP2. Individuals with cherubism present with symmetrical fibroosseous lesions of the jaw, which are attributed to exacerbated osteoclast activation and defective osteoblast differentiation. Although it is a dominant trait in humans, cherubism appears to be recessively transmitted in mice, suggesting the existence of additional factors in the pathogenesis of cherubism. Here, we report that macrophages from 3BP2-deficient mice exhibited dramatically reduced inflammatory responses to microbial challenge and reduced phagocytosis. 3BP2 was necessary for LPS-induced activation of signaling pathways involved in macrophage function, including SRC, VAV1, p38MAPK, IKKα/β, RAC, and actin polymerization pathways. Conversely, we demonstrated that the presence of a single Sh3bp2 cherubic allele and pathogen-associated molecular pattern (PAMP) stimulation had a strong cooperative effect on macrophage activation and inflammatory responses in mice. Together, the results from our study in murine genetic models support the notion that infection may represent a driver event in the etiology of cherubism in humans and suggest limiting inflammation in affected individuals may reduce manifestation of cherubic lesions. Figure 4) , indicating that 3BP2 is not required for DC stimulation.
To determine the impact of microbial stimulation on cherubic macrophage, we used gene targeting to introduce into the murine Sh3bp2 gene the mutation Gly418Arg (Supplemental Figure 5 ), equivalent to the Gly420Arg mutation frequently found in cherubic patients (1). The phenotype of homozygous Sh3bp2 G418R (Sh3bp2
KI/KI
) mice was strikingly similar to that described for homozygous Sh3bp2 P416R mice, another cherubic mutant mouse generated by Ueki et al. (10) , with typical facial swelling associated with eyelid closure, bone loss, lymphadenopathy, monocytosis, and systemic inflammation, as revealed by constitutive high levels of inflammatory cytokines in Sh3bp2 KI/KI mouse serum (Supplemental Figure 6 ). In addition, we observed that 3BP2 Gly418Arg mutant proteins accumulated in BMM (Supplemental Figure 6F ). In contrast, heterozygous mice (Sh3bp2
WT/KI
) showed no gross abnormalities under germ-free housing conditions. However, a significant increase of inflammatory cytokines was detected in the serum of both Sh3bp2
WT/KI and Sh3bp2 KI/KI mice challenged with LPS (Figure 1C) . When stimulated in vitro with LPS, CpG ODN, or zymosan, TNF-α production by Sh3bp2
WT/KI and Sh3bp2 KI/KI BMM was enhanced compared with that of WT BMM ( Figure 1D ). Furthermore, heterozygous cherubic mice (Sh3bp2
) infected with high doses of E. coli were more sensitive to septic shock (Supplemental Figure 6 , G and H). These observations suggest that the association between a single cherubism allele and the PAMP challenge is sufficient to reach pathogenic levels of inflammatory cytokines. in mice. In response to in vivo LPS challenge, reduced levels of inflammatory cytokines (IL-6, IL-12p70, and TNF-α) were measured in the serum of Sh3bp2 KO/KO mice compared with WT animals (Sh3bp2 WT/WT ) ( Figure 1A ), suggesting that 3BP2 is essential for the inflammatory function of macrophages. As a control, analysis of the number and phenotype of blood monocytes and spleen macrophages in WT and Sh3bp2 KO/KO mice indicated that 3BP2 was dispensable for proliferation and differentiation of monocytes and macrophages under steady-state conditions (Supplemental Figure 1 ; supplemental material available online with this article; doi:10.1172/JCI71081DS1). Importantly, macrophage recruitment to the peritoneal cavity in response to LPS or thioglycolate injections was unaffected in Sh3bp2 KO/KO mice (Supplemental Figure  2) . Adoptive transfer of thioglycolate-elicited peritoneal WT and Sh3bp2 KO/KO macrophages into macrophage-depleted mice followed by in vivo LPS stimulation further demonstrated that the defect in inflammatory reaction was intrinsic to Sh3bp2 KO/KO macrophages (Supplemental Figure 3) . To confirm the role of 3BP2 in macrophage, BM-derived macrophages (BMM) were generated in vitro and challenged with bona fide PAMP: LPS, CpG oligodeoxynucleotide (CpG ODN), or zymosan depleted of TLR-stimulating properties. The concentration of TNF-α in the supernatant of Sh3bp2 KO/KO BMM was reduced in response to all 3 stimuli, suggesting that in addition to TLR signaling, 3BP2 deficiency also affects DECTIN1 signaling ( Figure 1B) . Note that expression of TLR4, TLR9, and DECTIN1, receptors for LPS, CpG ODN, and zymosan, respectively, was unchanged on Sh3bp2 KO/KO macrophages (Supplemental Figure 1, D and E) . Also, LPS-stimulated BM-derived D) ; Kruskal-Wallis test (C). *P < 0.05; **P < 0.01; ***P < 0.001. jci.org control gene transcription and cytoskeletal changes in stimulated macrophages (18, 19) . Accordingly, 3BP2 bound SRC and VAV1 in BMM extracts ( Figure 3A) . Upon LPS stimulation, phosphorylation of SRC and VAV1 was reduced in Sh3bp2 KO/KO BMM, along with activation of signaling proteins required for inflammatory cytokine production, including JNK1/2, p38, and IKKα/β ( Figure 3B ). Absence of 3BP2 in resting and LPS-stimulated macrophages also reduced RAC activity ( Figure 3D ) and actin polymerization ( Figure 3E ). In addition, LPS-induced actin polymerization was diminished in Sh3bp2 KO/KO peritoneal macrophages, but not DC (Supplemental Figure 7) , and Sh3bp2 KO/KO BMM were impaired in their capacity to differentiate into multinucleated osteoclasts (Supplemental Figure 8) . Importantly, cytochalasin B decreased IL-6 production by LPS-stimulated WT macrophages (32% of reduction compared with untreated LPS-stimulated cells). This effect was more pronounced in Sh3bp2 KO/KO macrophages (68% of reduction compared with untreated LPS-stimulated cells) ( Table 1) . Further supporting the notion that actin dynamics in macrophage is a key event downstream of 3BP2, IL-6 secretion by LPS-stimulated Sh3bp2 KO/KO BMM was restored to normal levels by the actin-polymerizing agent jasplakinolide (Table 1) . We next determined how these 3BP2-associated signaling pathways were affected in cherubic BMM. When compared with WT macrophages, unstimulated homozygous cherubic macrophages exhibited constitutive levels of phosphorylation of several signaling components, including p38, SRC, and VAV1 ( Figure 3C ), and of RAC activity ( Figure 3D ), a phenomenon likely related to the autoinflammatory condition of these cells. Strikingly, depleting the commensal microbiota with oral antibiotic treatment did not decrease the inflammation in homozygous cherubic mice (Supplemental Figure 9) . However, in agreement with a recent study (20) , crossing Sh3bp2 KI/KI mice with Myd88 KO/KO mice reduced serum TNF-α to WT levels, demonstrating the involvement of TLR signaling in autoinflammation of homozygous cherubic mice ( Figure 3F ). Most importantly, LPSstimulated heterozygous cherubic BMM displayed enhanced signaling activities compared with WT macrophages (Figure 3 , C and D), and heterozygous cherubic mice (Sh3bp2
) orally treated with chronic LPS stimulation presented serum TNF-α levels similar to those found in untreated homozygous cherubic mice ( Figure  3G and Supplemental Figure 6E ). Our results in mouse models of normal and pathological 3BP2 function indicate that a complex between 3BP2, SRC, and VAV1 may bridge pathogen recognition to RAC activation and actin cytoskeleton remodeling, key processes of macrophage functions. In support of this notion, activation of small RHO GTPases has been recently recognized as a process induced by cytosolic microbial products detected by NOD1 (21) . Finally, our data reveal that an increased threshold of TLR signaling, and potentially of other PAMP receptors, associated with monoallelic SH3BP2 mutation may exacerbate macrophage sensitivity to microbial stimuli in cherubism-affected individuals. Upon oral infection, this aberrant process would hence initiate a We next investigated the role of 3BP2 in macrophage phagocytosis. In vitro phagocytosis assays with nonopsonized and Abopsonized fluorescent E. coli showed that 3BP2 was required for both Ab-dependent and -independent phagocytosis (Figure 2, A  and B) . Consistently, in vivo E. coli clearance was less efficient in Sh3bp2 KO/KO animals ( Figure 2C ). Conversely, phagocytic capacity of heterozygous cherubic BMM was exacerbated compared with that of WT macrophages ( Figure 2D ). TLR and Fc receptors signal via different cytosolic molecular pathways (14, 15) , and 3BP2 has been implicated in a variety of membrane receptor signaling pathways, including those stimulated by immunoreceptors (4, 5), RANK (8) , and GPCR (16) . Therefore, it seems unlikely that 3BP2 interacts with specific regulators of either TLR or Fc receptor pathways in macrophages. Indeed, Sh3bp2 KO/KO BMM were also ineffective in phagocyting latex beads ( Figure 2E ).
Our observations thus indicate that 3BP2 function during pathogen recognition by macrophages is related to a general cellular process. The necessity of actin cytoskeleton remodeling during phagocytosis is well known (17) . Consistently, the increased activity of E. coli engulfment observed in heterozygous cherubic BMM was blocked by the actin-depolymerizing drug cytochalasin B ( Figure 2D ). 3BP2-mediated signaling in leukocyte involved interactions with SRC and SYK kinases and VAV GEF (2), which 
Methods
Further information is available in Supplemental Methods. Mice and in vivo experiments. Mice were on a C57BL/6 background.
Sh3bp2
KO/KO (6) and Myd88 KO/KO (22) mice have been described. Cherubic mice were generated by the Institut Clinique de la Souris (ICS) by knocking-in (KI) the GGA-to-CGA mutation in the Sh3bp2 exon 9, resulting in a Gly418-to-Arg substitution in 3BP2 protein (Supplemental Figures 5 and  6 and Supplemental Methods). In vivo experiments were performed on 8-to 12-week-old mice as described in Supplemental Methods. BMM differentiation and in vitro assays. Cells were flushed out of mouse femurs and tibias and cultured for 5 to 7 days at 37°C, 5% CO 2 , in RPMI, 50 U/l penicillin, 50 μg/l streptomycin, 1 mM sodium pyruvate, 10 μM HEPES, 10% FBS, and 50 ng/ml M-CSF. BMM were stimulated for 16 hours with LPS (E. coli strain 055:B5, Sigma- ELISA in the serum of untreated mice (n = 6). (G) LPS was added for 28 days in mouse drinking water, and TNF-α in the serum was measured by ELISA (n = 6). P values were determined by the following tests: 2-way ANOVA (D, E and G); (Kruskal-Wallis test (F). *P < 0.05; **P < 0.01; ***P < 0.001. 
